Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results.
Kerbel
R S
RS
Department of Medical Biophysics, University of Toronto, Toronto, Canada. robert.kerbel@swchsc.on.ca
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D019317:Evidence-Based Medicine; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000503:physiopathology; D009389:Neovascularization, Pathologic; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors